Maria Alsina Maqueda

16PUBLICATIONS
82CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Mar 05, 2026
SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of esophageal cancer (update 2025).

Ana Fernández-Montes, Julia Alcaide, Ana Belén Custodio

|Jun 28, 2025
Correction: Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas

|May 19, 2025
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Maria Alsina, Guillermo Villacampa, Carlos de Andrea

|Mar 12, 2025
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas

|Jul 18, 2024
SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of gastric cancer (2023).

Fernando Rivera, Federico Longo, Marta Martín Richard

Pageof 3

Frequent Collaborators

3 joint publications

Josep Tabernero

3 joint publications

Marc Diez

3 joint publications

Fernando Rivera Herrero

3 joint publications

Paula Jimenez-Fonseca